Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × encorafenib × 90 days × Clear all

Phase

Status

Active not recruiting 8 Recruiting 7 Completed 3 Terminated 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 5 pembrolizumab 4 fludarabine 3 Prednisone 3 Paclitaxel 3 Doxorubicin 3 tazemetostat 2 ribociclib 2 regorafenib 2 fludarabine phosphate 2 decitabine and cedazuridine drug combination 2 atezolizumab 2 Vincristine 2 Tiragolumab 2 Rituximab 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Blood Specimen Collection 2 Biopsy 2 ALT-803 2 venetoclax 1 tremelimumab 1 trastuzumab deruxtecan 1 tislelizumab 1 tafasitamab 1 semaglutide 1 peginterferon alfa-2a 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07092410 2026-04-21

SuRage-EB

SRH Wald-Klinikum Gera GmbH

Phase 4 Withdrawn

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡